Originally published in the Health Care Fraud Report, 17 HFRA 219, on 03/06/2013.
The final rule (the ‘‘Final Rule’’) implementing the Physician Payments Sunshine Act (‘‘Sunshine Act’’), published in the Federal Register on February 8, 2013 provides key definitions and terms, broad reporting requirements, important exemptions and limitations, and additional reporting guidance.
The Sunshine Act requires manufacturers of drugs, devices, biologics, or medical supplies covered by Medicare, Medicaid, or the Children’s Health Insurance Program (‘‘CHIP’’) (each a ‘‘Covered Product’’) to report payments and other transfers of value to physicians and teaching hospitals (‘‘covered recipients’’). The Sunshine Act also requires such manufacturers (collectively, ‘‘Manufacturers’’) and Group Purchasing Organizations (‘‘GPOs’’) to disclose ownership or investment interests held by physicians or their immediate family members.
Please see full alert below for more information.
Firefox recommends the PDF Plugin for Mac OS X for viewing PDF documents in your browser.
We can also show you Legal Updates using the Google Viewer; however, you will need to be logged into Google Docs to view them.
Please choose one of the above to proceed!
LOADING PDF: If there are any problems, click here to download the file.
Topics: CMS, Drug Manufacturers, Joint Purchasing Programs, Physicians, Sunshine Act
Published In: General Business Updates, Finance & Banking Updates, Health Updates, Insurance Updates, Science, Computers & Technology Updates
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Mintz Levin - Health Law & Policy Matters | Attorney Advertising